Article Versions Notes

Ismael N, Hussein C, Magul C, Inguane H, Couto A, Nhangave A, Muteerwa A, Bonou M, Ramos A, Young PW, et al. HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique. Pathogens. 2025; 14(1):48. https://doi.org/10.3390/pathogens14010048

Ismael, Nalia, Cidia Hussein, Cacildo Magul, Humberto Inguane, Aleny Couto, Amancio Nhangave, Ana Muteerwa, Mahoudo Bonou, Artur Ramos, Peter Wesley Young, and et al. 2025. "HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique" Pathogens 14, no. 1: 48. https://doi.org/10.3390/pathogens14010048

Ismael, N., Hussein, C., Magul, C., Inguane, H., Couto, A., Nhangave, A., Muteerwa, A., Bonou, M., Ramos, A., Young, P. W., Chilundo, S., Machekano, R., Greenberg, L., da Silva, J., & Bhatt, N. (2025). HIV Drug Resistance Profile in Clients Experiencing Treatment Failure After the Transition to a Dolutegravir-Based First-Line Antiretroviral Treatment Regimen in Mozambique. Pathogens, 14(1), 48. https://doi.org/10.3390/pathogens14010048